共 50 条
- [21] ACELLULAR PERTUSSIS-VACCINE COMPOSED OF GENETICALLY INACTIVATED PERTUSSIS TOXIN - SAFETY AND IMMUNOGENICITY IN 12-MONTH-OLD TO 24-MONTH-OLD AND 2-MONTH-OLD TO 4-MONTH-OLD CHILDREN [J]. JOURNAL OF PEDIATRICS, 1992, 120 (05): : 680 - 685
- [25] INSTABILITY OF PERTUSSIS-VACCINE COMPONENT IN QUADRUPLE ANTIGEN VACCINE - DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS AND POLIOMYELITIS VACCINES [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 181 (01): : 25 - &
- [28] DIPHTHERIA, TETANUS, AND PERTUSSIS-VACCINE - A COMPARISON OF THE IMMUNE-RESPONSE AND ADVERSE REACTIONS TO CONVENTIONAL AND ACELLULAR PERTUSSIS COMPONENTS [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1986, 140 (09): : 867 - 871
- [30] EFFICACY AND IMMUNOGENICITY OF ACELLULAR PERTUSSIS-VACCINE BY MANUFACTURER AND PATIENT AGE [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1989, 143 (06): : 655 - 659